NEIDL Researchers Discover New SARS-CoV-2 Weak Spot—Which Could Inspire Improved Vaccines | BU Today

CEID Faculty Dr. John Connor and a team of NEIDL researchers suggest that Omicron’s protein mutation and changes in its spike protein contribute to decreased severity of symptoms and increased ability to evade immunity.